news

Chicken eggs used to produce SARS-CoV-2 antibodies

Researchers in the US have found that antibodies to the SARS-CoV-2 Spike protein can be produced in hen eggs.

Eggs to produce SARS-CoV-2 antibodies

Researchers from the University of California, Davis, US have produced antibodies to the SARS-CoV-2 Spike (S) protein in chicken eggs. According to the team, antibodies harvested from eggs could treat COVID-19 or be used as a preventative measure for people exposed to the disease, as outlined in the work published in the journal Viruses.

“The beauty of the system is that you can produce a lot of antibodies in birds,” said Professor Rodrigo Gallardo, one of the lead researchers on the study. “In addition to a low cost to produce these antibodies in hens, they can be updated very fast by using updated antigens to hyperimmunise hens, allowing protection against current variant strains.”   

The researchers explain that birds produce a type of antibody called IgY, comparable to IgG in humans and other mammals. IgY does not cause allergy or set off immune reactions when injected into humans and it appears both in birds’ serum and in their eggs. 

 

Reserve your FREE place

 


Are you looking to optimise antibody leads in your drug discovery? Register for this webinar to find out how!

30 July 2025 | 10:00 AM BST | FREE Webinar

Join this webinar to hear from Dr. Lei Guo as she shares how early insights into liability, PK, stability, and manufacturability can help you optimise antibody leads in early drug discovery – and mitigate downstream risks later in development.

What You’ll Learn:

  • How to assess key developability risks early
  • How in silico modelling and in vitro testing can be combined to predict CMC risks earlier in discovery stage
  • How micro-developability strategies are tailored for complex or novel formats

Don’t miss your chance to learn from real-world leaders

Register Now – It’s Free!

 

Gallardo and colleagues immunised hens with two doses of three different vaccines based on the SARS-CoV-2 S protein or receptor binding domain. They then measured antibodies in blood samples from the hens and in egg yolks three and six weeks after the last immunisation.

The scientists then tested purified antibodies for their ability to block the coronavirus from infecting human cells. Both eggs and sera from immunised hens contained antibodies that recognised SARS-CoV-2. Antibodies from serum were more effective in neutralising the virus, which the researchers say is likely because there are more antibodies in blood overall.

Gallardo is now working with colleagues to develop the egg-based antibody technology. The team hopes to deploy these antibodies in a preventative treatment such as a spray, that could be used by people at high risk of exposure to coronavirus.

Leave a Reply

Your email address will not be published. Required fields are marked *